{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T03:48:01Z","timestamp":1771040881865,"version":"3.50.1"},"reference-count":22,"publisher":"Siapec Servizi Srl","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologica"],"DOI":"10.32074\/1591-951x-n1157","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T15:06:36Z","timestamp":1763391996000},"page":"423-429","source":"Crossref","is-referenced-by-count":1,"title":["A novel germline NF1 splicing variant drives the onset of an anorectal mucosal melanoma in a patient with a stable and durable nivolumab response"],"prefix":"10.32074","volume":"117","author":[{"given":"Enrico","family":"Berrino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara Erika","family":"Bellomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Mastorino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Morbidoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Crosetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Sapino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Sarotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Chesta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avallone","family":"Gianluca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Quaglino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Zampieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Senetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Trevisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Marchi\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Ribero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"21774","published-online":{"date-parts":[[2025,10]]},"reference":[{"key":"10.32074\/1591-951X-N1157_ref1","doi-asserted-by":"crossref","unstructured":"Cirenajwis H, Lauss M, Ekedahl H, et al. NF1-mutated melanoma tumors harbor distinct clinical and biological characteristics. Mol Oncol. Apr 2017;11(4):438-451. https:\/\/doi.org\/10.1002\/1878-0261.12050","DOI":"10.1002\/1878-0261.12050"},{"key":"10.32074\/1591-951X-N1157_ref2","doi-asserted-by":"crossref","unstructured":"Thielmann CM, Chorti E, Matull J, et al. NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors. Eur J Cancer. Dec 2021;159:113-124. https:\/\/doi.org\/10.1016\/j.ejca.2021.09.035","DOI":"10.1016\/j.ejca.2021.09.035"},{"key":"10.32074\/1591-951X-N1157_ref3","doi-asserted-by":"crossref","unstructured":"Kiuru M, Busam KJ. The NF1 gene in tumor syndromes and melanoma. Lab Invest. Feb 2017;97(2):146-157. https:\/\/doi.org\/10.1038\/labinvest.2016.142","DOI":"10.1038\/labinvest.2016.142"},{"key":"10.32074\/1591-951X-N1157_ref4","doi-asserted-by":"crossref","unstructured":"Spencer KR, Mehnert JM. Mucosal Melanoma: Epidemiology, Biology and Treatment. Cancer Treat Res. 2016;167:295-320. https:\/\/doi.org\/10.1007\/978-3-319-22539-5_13","DOI":"10.1007\/978-3-319-22539-5_13"},{"key":"10.32074\/1591-951X-N1157_ref5","doi-asserted-by":"crossref","unstructured":"Zhang N, Harbers L, Simonetti M, et al. High clonal diversity and spatial genetic admixture in early prostate cancer and surrounding normal tissue. Nat Commun. Apr 24 2024;15(1):3475. https:\/\/doi.org\/10.1038\/s41467-024-47664-z","DOI":"10.1038\/s41467-024-47664-z"},{"key":"10.32074\/1591-951X-N1157_ref6","doi-asserted-by":"crossref","unstructured":"Zhang X, Garnerone S, Simonetti M, et al. CUTseq is a versatile method for preparing multiplexed DNA sequencing libraries from low-input samples. Nat Commun. Oct 18 2019;10(1):4732. https:\/\/doi.org\/10.1038\/s41467-019-12570-2","DOI":"10.1038\/s41467-019-12570-2"},{"key":"10.32074\/1591-951X-N1157_ref7","doi-asserted-by":"crossref","unstructured":"Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. May 2012;2(5):401-4. https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0095","DOI":"10.1158\/2159-8290.CD-12-0095"},{"key":"10.32074\/1591-951X-N1157_ref8","doi-asserted-by":"crossref","unstructured":"Berrino E, Filippi R, Visintin C, et al. Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitors. NPJ Precis Oncol. Mar 8 2022;6(1):15. https:\/\/doi.org\/10.1038\/s41698-022-00258-8","DOI":"10.1038\/s41698-022-00258-8"},{"key":"10.32074\/1591-951X-N1157_ref9","doi-asserted-by":"crossref","unstructured":"Morbidoni V, Baschiera E, Forzan M, et al. Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of NF1 Variants. Cancers (Basel). Feb 27 2021;13(5)https:\/\/doi.org\/10.3390\/cancers13050999","DOI":"10.3390\/cancers13050999"},{"key":"10.32074\/1591-951X-N1157_ref10","doi-asserted-by":"crossref","unstructured":"Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. May 2015;17(5):405-24. https:\/\/doi.org\/10.1038\/gim.2015.30","DOI":"10.1038\/gim.2015.30"},{"key":"10.32074\/1591-951X-N1157_ref11","unstructured":"BioRad. Macrophages Polarization Minireview. Accessed December, 2023. (https:\/\/www.bio-rad-antibodies.com\/macrophage-polarization-minireview.html)"},{"key":"10.32074\/1591-951X-N1157_ref12","doi-asserted-by":"crossref","unstructured":"Jour G, Illa-Bochaca I, Ibrahim M, et al. Genomic and Transcriptomic Analyses of NF1-Mutant Melanoma Identify Potential Targeted Approach for Treatment. J Invest Dermatol. Mar 2023;143(3):444-455 e8. https:\/\/doi.org\/10.1016\/j.jid.2022.07.022","DOI":"10.1016\/j.jid.2022.07.022"},{"key":"10.32074\/1591-951X-N1157_ref13","doi-asserted-by":"crossref","unstructured":"Soon C, Humphreys F, Carr RA. Rectal melanoma arising in association with neurofibromatosis type I. Clin Exp Dermatol. Mar 2008;33(2):207-9. https:\/\/doi.org\/10.1111\/j.1365-2230.2007.02614.x","DOI":"10.1111\/j.1365-2230.2007.02614.x"},{"key":"10.32074\/1591-951X-N1157_ref14","doi-asserted-by":"crossref","unstructured":"Ishii S, Han S, Shiiba K, et al. Allelic loss of the NF1 gene in anal malignant melanoma in a patient with neurofibromatosis type 1. Int J Clin Oncol. Aug 2001;6(4):201-4. https:\/\/doi.org\/10.1007\/pl00012105","DOI":"10.1007\/PL00012105"},{"key":"10.32074\/1591-951X-N1157_ref15","unstructured":"Ben-Izhak O, Groisman GM. Anal malignant melanoma and soft-tissue malignant fibrous histiocytoma in neurofibromatosis type 1. Arch Pathol Lab Med. Mar 1995;119(3):285-8."},{"key":"10.32074\/1591-951X-N1157_ref16","unstructured":"Garcia-Casasola G, Casado A, Ciguenza R, Gonzalez Larriba JL, Alvarez-Sala JL. [Rectal melanoma and von Recklinghausen\u2019s disease]. Rev Clin Esp. May 1992;190(9):475-6. Melanoma rectal y enfermedad de von Recklinghausen."},{"key":"10.32074\/1591-951X-N1157_ref17","doi-asserted-by":"crossref","unstructured":"D\u2019Angelo SP, Larkin J, Sosman JA, et al. Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis. J Clin Oncol. Jan 10 2017;35(2):226-235. https:\/\/doi.org\/10.1200\/JCO.2016.67.9258","DOI":"10.1200\/JCO.2016.67.9258"},{"key":"10.32074\/1591-951X-N1157_ref18","doi-asserted-by":"crossref","unstructured":"Buchbinder EI, Weirather JL, Manos M, et al. Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockade. Cancer Med. Apr 2021;10(8):2627-2635. https:\/\/doi.org\/10.1002\/cam4.3789","DOI":"10.1002\/cam4.3789"},{"key":"10.32074\/1591-951X-N1157_ref19","doi-asserted-by":"crossref","unstructured":"Jia J, Zhang H, Zhang H, Liu W, Shu M. Infiltrating Macrophages Induced Stem-cell-like Features Through PI3K\/AKT\/GSK3beta Signaling to Promote Neurofibroma Growth. Arch Med Res. Feb 2020;51(2):124-134. https:\/\/doi.org\/10.1016\/j.arcmed.2019.12.018","DOI":"10.1016\/j.arcmed.2019.12.018"},{"key":"10.32074\/1591-951X-N1157_ref20","doi-asserted-by":"crossref","unstructured":"Duan Z, Luo Y. Targeting macrophages in cancer immunotherapy. Signal Transduct Target Ther. Mar 26 2021;6(1):127. https:\/\/doi.org\/10.1038\/s41392-021-00506-6","DOI":"10.1038\/s41392-021-00506-6"},{"key":"10.32074\/1591-951X-N1157_ref21","doi-asserted-by":"crossref","unstructured":"Berrino E, Filippi R, Visintin C, et al. Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitors. NPJ Precis Oncol. Mar 8 2022;6(1):15. https:\/\/doi.org\/10.1038\/s41698-022-00258-8","DOI":"10.1038\/s41698-022-00258-8"},{"key":"10.32074\/1591-951X-N1157_ref22","doi-asserted-by":"crossref","unstructured":"Morbidoni V, Baschiera E, Forzan M, et al. Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of NF1 Variants. Cancers (Basel). Feb 27 2021;13(5). https:\/\/doi.org\/10.3390\/cancers13050999","DOI":"10.3390\/cancers13050999"}],"container-title":["Pathologica"],"original-title":[],"link":[{"URL":"https:\/\/www.pathologica.it\/article\/view\/1157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T15:07:32Z","timestamp":1763392052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.pathologica.it\/article\/view\/1157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,9]]}},"URL":"https:\/\/doi.org\/10.32074\/1591-951x-n1157","relation":{},"ISSN":["1591-951X"],"issn-type":[{"value":"1591-951X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]},"article-number":"15"}}